<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-GMIHT2L6/bd93a27e-cae5-4f7f-b7d1-d1874a42c96d/PDF"><dcterms:extent>1297 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-GMIHT2L6/a6b897b0-53a4-406d-9c8e-bf8e3a49bfcc/TEXT"><dcterms:extent>28 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2005-2025"><edm:begin xml:lang="en">2005</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-GMIHT2L6"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN" /><dcterms:issued>2022</dcterms:issued><dc:creator>Bolčina, Lara</dc:creator><dc:creator>Kos, Janko</dc:creator><dc:creator>Pišlar, Anja</dc:creator><dc:format xml:lang="sl">številka:5</dc:format><dc:format xml:lang="sl">letnik:73</dc:format><dc:format xml:lang="sl">str. 403-409</dc:format><dc:identifier>ISSN:0014-8229</dc:identifier><dc:identifier>COBISSID_HOST:132623619</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-GMIHT2L6</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko farmacevtsko društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Farmacevtski vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">Alzheimerjeva bolezen</dc:subject><dc:subject xml:lang="sl">cisteinski katepsini</dc:subject><dc:subject xml:lang="sl">nevrodegeneracija</dc:subject><dc:subject xml:lang="sl">Nevrodegenerativne bolezni</dc:subject><dc:subject xml:lang="sl">Parkinsonova bolezen</dc:subject><dc:subject xml:lang="sl">vnetni odziv</dc:subject><dcterms:temporal rdf:resource="2005-2025" /><dc:title xml:lang="sl">Pomen cisteinskih peptidaz pri nevrodegenerativnih boleznih| Importance of cysteine peptidases in neurodegenerative disorders|</dc:title><dc:description xml:lang="sl">The nervous system represents a broad field of potential pharmacological targets suitable for the development of new compounds for the treatment of neurological and neurodegenerative diseases. To date, a lot of research has focused on the role of cysteine peptidases, which play an important role in degradation of brain peptides playing either a neuroprotective or neurodegenerative role. Activated microglia has a significant role in inflammation-related neurodegeneration. By releasing cysteine cathepsins it promotes the development of Alzheimer's and Parkinson's disease. The proteolytic activity of cysteine cathepsins can be regulated by endogenous or exogenous inhibitors. Exogenous inhibitors open up possibilities for the development of new therapeutic approaches for the treatment of neurodegenerative diseases</dc:description><dc:description xml:lang="sl">Živčni sistem predstavlja široko raziskovalno področje za razvoj novih učinkovin, primernih za zdravljenje nevroloških in nevrodegenerativnih bolezni. Pri tem imajo pomembno vlogo cisteinske peptidaze in drugi lizosomski proteini, ki s svojim delovanjem vplivajo na sintezo in razgradnjo možganskih peptidov ter tako regulirajo številne fiziološke in patološke procese v organizmu. Ključni pomen pri z vnetjem povezani nevrodegeneraciji ima aktivirana mikroglija, ki s sproščanjem cisteinskih peptidaz vpliva na razvoj Alzheimerjeve in Parkinsonove bolezni. Proteolitično aktivnost cisteinskih peptidaz lahko regulirajo endogeni ali eksogeni zaviralci; slednji odpirajo možnosti za razvoj novih terapevtskih pristopov za zdravljenje nevrodegenerativnih bolezni</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-GMIHT2L6"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-GMIHT2L6" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-GMIHT2L6/bd93a27e-cae5-4f7f-b7d1-d1874a42c96d/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko farmacevtsko društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-GMIHT2L6/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-GMIHT2L6" /></ore:Aggregation></rdf:RDF>